420 related articles for article (PubMed ID: 36232720)
1. Migraine Pharmacological Treatment and Cognitive Impairment: Risks and Benefits.
Russo M; De Rosa MA; Calisi D; Consoli S; Evangelista G; Dono F; Santilli M; Granzotto A; Onofrj M; Sensi SL
Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232720
[TBL] [Abstract][Full Text] [Related]
2. Association between migraine and cognitive impairment.
Gu L; Wang Y; Shu H
J Headache Pain; 2022 Jul; 23(1):88. PubMed ID: 35883043
[TBL] [Abstract][Full Text] [Related]
3. Topiramate in Migraine Prevention: A 2016 Perspective.
Silberstein SD
Headache; 2017 Jan; 57(1):165-178. PubMed ID: 27902848
[TBL] [Abstract][Full Text] [Related]
4. Cognitive dysfunction and migraine.
Vuralli D; Ayata C; Bolay H
J Headache Pain; 2018 Nov; 19(1):109. PubMed ID: 30442090
[TBL] [Abstract][Full Text] [Related]
5. Cognition and Cognitive Impairment in Migraine.
Gil-Gouveia R; Martins IP
Curr Pain Headache Rep; 2019 Sep; 23(11):84. PubMed ID: 31511992
[TBL] [Abstract][Full Text] [Related]
6. Early Age of Migraine Onset is Independently Related to Cognitive Decline and Symptoms of Depression Affect Quality of Life.
Bao J; Ma M; Dong S; Gao L; Li C; Cui C; Chen N; Zhang Y; He L
Curr Neurovasc Res; 2020; 17(2):177-187. PubMed ID: 32031072
[TBL] [Abstract][Full Text] [Related]
7. Neuropsychological assessment in migraine patients: a descriptive review on cognitive implications.
Foti M; Lo Buono V; Corallo F; Palmeri R; Bramanti P; Marino S
Neurol Sci; 2017 Apr; 38(4):553-562. PubMed ID: 28101762
[TBL] [Abstract][Full Text] [Related]
8. Brain lesions and cerebral functional impairment in migraine patients.
Paemeleire K
J Neurol Sci; 2009 Aug; 283(1-2):134-6. PubMed ID: 19268310
[TBL] [Abstract][Full Text] [Related]
9. Cognitive Decline in Chronic Migraine with Nonsteroid Anti-inflammation Drug Overuse: A Cross-Sectional Study.
Cai X; Xu X; Zhang A; Lin J; Wang X; He W; Fang Y
Pain Res Manag; 2019; 2019():7307198. PubMed ID: 31198478
[TBL] [Abstract][Full Text] [Related]
10. Preventive treatment can reverse cognitive impairment in chronic migraine.
González-Mingot C; Gil-Sánchez A; Canudes-Solans M; Peralta-Moncusi S; Solana-Moga MJ; Brieva-Ruiz L
J Headache Pain; 2022 Sep; 23(1):121. PubMed ID: 36109696
[TBL] [Abstract][Full Text] [Related]
11. Safety of drugs used for the treatment of migraine during pregnancy: a narrative review.
Spiteri JA; Camilleri G; Piccinni C; Sultana J
Expert Rev Clin Pharmacol; 2023 Mar; 16(3):207-217. PubMed ID: 36803196
[TBL] [Abstract][Full Text] [Related]
12. The burden of migraine in the United States: current and emerging perspectives on disease management and economic analysis.
Hazard E; Munakata J; Bigal ME; Rupnow MF; Lipton RB
Value Health; 2009; 12(1):55-64. PubMed ID: 18671771
[TBL] [Abstract][Full Text] [Related]
13. Survey on treatments for primary headaches in 13 specialized juvenile Headache Centers: The first multicenter Italian study.
Toldo I; Rattin M; Perissinotto E; De Carlo D; Bolzonella B; Nosadini M; Rossi LN; Vecchio A; Simonati A; Carotenuto M; Scalas C; Sciruicchio V; Raieli V; Mazzotta G; Tozzi E; Valeriani M; Cianchetti C; Balottin U; Guidetti V; Sartori S; Battistella PA
Eur J Paediatr Neurol; 2017 May; 21(3):507-521. PubMed ID: 28082014
[TBL] [Abstract][Full Text] [Related]
14. [Primary headache - risk factor or comorbid pathology in cognitive impairment].
Iskra DA; Lobzin VY; Kalygin SA
Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(12):141-146. PubMed ID: 29376997
[TBL] [Abstract][Full Text] [Related]
15. Sumatriptan nasal spray and cognitive function during migraine: results of an open-label study.
Farmer K; Cady R; Bleiberg J; Reeves D; Putnam G; O'Quinn S; Batenhorst A
Headache; 2001 Apr; 41(4):377-84. PubMed ID: 11318884
[TBL] [Abstract][Full Text] [Related]
16. Choosing the safest acute therapy during chronic migraine prophylactic treatment: pharmacokinetic and pharmacodynamic considerations.
Lionetto L; Borro M; Curto M; Capi M; Negro A; Cipolla F; Gentile G; Martelletti P
Expert Opin Drug Metab Toxicol; 2016; 12(4):399-406. PubMed ID: 26878379
[TBL] [Abstract][Full Text] [Related]
17. Neuropsychology of migraine: present status and future directions.
O'Bryant SE; Marcus DA; Rains JC; Penzien DB
Expert Rev Neurother; 2005 May; 5(3):363-70. PubMed ID: 15938669
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological synergy: the next frontier on therapeutic advancement for migraine.
Blumenfeld A; Gennings C; Cady R
Headache; 2012 Apr; 52(4):636-47. PubMed ID: 22221151
[TBL] [Abstract][Full Text] [Related]
19. The acute treatment of migraine in adults: the american headache society evidence assessment of migraine pharmacotherapies.
Marmura MJ; Silberstein SD; Schwedt TJ
Headache; 2015 Jan; 55(1):3-20. PubMed ID: 25600718
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
